119 related articles for article (PubMed ID: 20463426)
1. Gene therapy for prostate cancer.
Tangney M; Ahmad S; Collins SA; O'Sullivan GC
Postgrad Med; 2010 May; 122(3):166-80. PubMed ID: 20463426
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. [Adenocarcinoma of the prostate].
Dvorácek J
Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
[TBL] [Abstract][Full Text] [Related]
4. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
Hwang C; Sanda MG
Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
[TBL] [Abstract][Full Text] [Related]
5. New prospectives of prostate cancer gene therapy: molecular targets and animal models.
Hsieh CL; Chung LW
Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):77-120. PubMed ID: 11693967
[TBL] [Abstract][Full Text] [Related]
6. Is gene therapy the answer for prostate cancer?
Patel P; Ashdown D; James N
Prostate Cancer Prostatic Dis; 2004 Sep; 7 Suppl 1():S14-9. PubMed ID: 15365577
[TBL] [Abstract][Full Text] [Related]
7. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
8. In situ gene therapy for prostate cancer.
Thompson TC
Oncol Res; 1999; 11(1):1-8. PubMed ID: 10451026
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer gene therapy: outcome of basic research and clinical trials.
Nasu Y; Djavan B; Marberger M; Kumon H
Tech Urol; 1999 Dec; 5(4):185-90. PubMed ID: 10591255
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer gene therapy and the role of radiation.
Kaminski JM; Nguyen K; Buyyounouski M; Pollack A
Cancer Treat Rev; 2002 Feb; 28(1):49-64. PubMed ID: 12027414
[TBL] [Abstract][Full Text] [Related]
11. Biological principles and clinical development of prostate cancer gene therapy.
Sanda MG
Semin Urol Oncol; 1997 Feb; 15(1):43-55. PubMed ID: 9050139
[TBL] [Abstract][Full Text] [Related]
12. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
13. Current status of experimental therapeutics for prostate cancer.
Moon C; Park JC; Chae YK; Yun JH; Kim S
Cancer Lett; 2008 Aug; 266(2):116-34. PubMed ID: 18440696
[TBL] [Abstract][Full Text] [Related]
14. Targeting of therapeutic agents to bone to treat metastatic cancer.
Bagi CM
Adv Drug Deliv Rev; 2005 May; 57(7):995-1010. PubMed ID: 15876400
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy for advanced prostate cancer: Looking through new lenses.
Vogiatzi P; Cassone M; Claudio L; Claudio PP
Drug News Perspect; 2009 Dec; 22(10):593-601. PubMed ID: 20140279
[TBL] [Abstract][Full Text] [Related]
16. [Clinical application for gene therapy in prostate cancer].
Gotoh A; Kamidono S; Chung LW
Hinyokika Kiyo; 1997 Nov; 43(11):829-33. PubMed ID: 9436031
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for prostate cancer.
Gdor Y; Timme TL; Miles BJ; Kadmon D; Thompson TC
Expert Rev Anticancer Ther; 2002 Jun; 2(3):309-21. PubMed ID: 12113054
[TBL] [Abstract][Full Text] [Related]
18. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.
Loberg RD; Logothetis CJ; Keller ET; Pienta KJ
J Clin Oncol; 2005 Nov; 23(32):8232-41. PubMed ID: 16278478
[TBL] [Abstract][Full Text] [Related]
20. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
